Biofrontera, Inc. (BFRI)
1.03
-0.03
(-2.83%)
USD |
NASDAQ |
Apr 23, 16:00
1.00
-0.03
(-2.91%)
After-Hours: 20:00
Biofrontera EPS Diluted (Quarterly) : 0.4842 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Align Technology, Inc. | 1.892 |
| Plus Therapeutics, Inc. | -1.03 |
| BioStem Technologies, Inc. | -0.67 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
| Protokinetix, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.64M |
| Revenue (Quarterly) | 17.10M |
| Total Expenses (Quarterly) | 11.46M |
| Enterprise Value | 11.76M |
| Gross Profit Margin (Quarterly) | 94.91% |
| Profit Margin (Quarterly) | 32.98% |
| Earnings Yield | -114.1% |
| Normalized Earnings Yield | -107.65 |